Fig. 3
Patients achieving ≥ 75% reduction in MMD during a) 12 weeks and at b) 4 weeks. MMD monthly migraine days. aP < 0.05 versus placebo
Fig. 3 | The Journal of Headache and Pain
Patients achieving ≥ 75% reduction in MMD during a) 12 weeks and at b) 4 weeks. MMD monthly migraine days. aP < 0.05 versus placebo